Skip to content

Amortization at other companies

Enpro logo
EnproNPO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$144.8M+6.8%
Gross profit$11.0M-28.5%
Operating income-$7.7M-588%
Net income-$8.2M-40,975%
EPS (diluted)-$0.40

Balance sheet

See full
Cash & equivalents$2.1M+1,029%
Total debt$30.6M+5.5%
Total equity$232.2M-7.1%
Total assets$578.1M+29.1%

Cash flow

See full
Operating cash flow-$2.8M-133%
CapEx$4.2M+41.3%
Free cash flow-$6.9M-229%

Valuation

See full
Market cap$899.68M+175%
Enterprise value$928.24M+161%
P/S1.6×+1.0×

Profitability

See full
Gross margin8.9%-2.9pp
Operating margin-2.4%-9.3pp
Net margin-2.9%-7.0pp
FCF margin2.8%-10.7pp

Returns & leverage

See full
Return on equity-6.8%-16.2pp
Debt / equity0.1×0.0×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Mayville Engineering in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentForAmortization.

The official record: Mayville Engineering’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mayville Engineering's amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mayville Engineering's amortization?
Mayville Engineering (MEC) reported amortization of $3.13M in Q1 2026.
How has Mayville Engineering's amortization changed year-over-year?
Mayville Engineering's amortization increased by 80.6% year-over-year, from $1.73M to $3.13M.
What is the long-term trend for Mayville Engineering's amortization?
Over 4 years (2021 to 2025), Mayville Engineering's amortization has grown at a -2.4% compound annual growth rate (CAGR), from $10.71M to $9.72M.